Renoprotective effect of DPP-4 inhibitors against free fatty acid-bound albumin-induced renal proximal tubular cell injury

Biochemical and Biophysical Research Communications
Yuki TanakaHiroshi Maegawa

Abstract

Dipeptidyl peptidase (DPP)-4 inhibitors, a new class of antidiabetic agent, have recently been suggested to exert pleiotropic effects beyond glucose lowering. Renal prognosis in patients with diabetic nephropathy depends on the severity of tubulointerstitial injury induced by massive proteinuria. We thus examined the renoprotective effect of DPP-4 inhibitors on inflammation in cultured mouse proximal tubular cells stimulated with free fatty acid (FFA)-bound albumin. Linagliptin and higher concentrations of sitagliptin, vildagliptin, and alogliptin all inhibited FFA-bound albumin-induced increases in mRNA expression of MCP-1 in cultured mouse proximal tubular cells. Furthermore, linagliptin significantly inhibited tubulointerstitial injury induced by peritoneal injection of FFA-bound albumin, such as inflammation, fibrosis, and apoptosis, in mice without altering systemic characteristics including body weight, fasting blood glucose, and food intake. These results indicate that DPP-4 inhibitors pleiotropically exert a direct renoprotective effect, and may serve as an additional therapeutic strategy to protect proximal tubular cells against proteinuria in patients with diabetic nephropathy.

References

Sep 10, 2002·American Journal of Physiology. Renal Physiology·Mark E ThomasNigel J Brunskill
Oct 10, 2002·Kidney International·Atsuko KamijoMasao Omata
Aug 3, 2006·Kidney International·P A Sarafidis, G L Bakris
Jun 30, 2009·Biopharmaceutics & Drug Disposition·Holger FuchsAndreas Greischel
Jan 30, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Pantelis A SarafidisAnastasios N Lasaridis
Aug 24, 2010·Regulatory Peptides·Jitendra VaghasiyaRavi Manek
Oct 13, 2010·Biochemical and Biophysical Research Communications·Mariko SoumuraTakashi Uzu
Oct 26, 2011·The Journal of Pharmacology and Experimental Therapeutics·Wei Jing LiuTae Sun Park
Mar 20, 2012·The American Journal of Cardiology·Steven G Chrysant, George S Chrysant
Nov 23, 2012·Kidney & Blood Pressure Research·Markus L AlterBerthold Hocher
Oct 4, 2013·International Journal of Endocrinology·Martin HaluzíkIvan Rychlík
Dec 18, 2013·Biochemical and Biophysical Research Communications·Ryo KoderaHirofumi Makino
Jan 16, 2014·Cardiovascular Diabetology·Christian OttRoland E Schmieder
Apr 9, 2014·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·S NakashimaS-I Yamagishi
May 13, 2014·Mediators of Inflammation·Catarina MarquesRosa Fernandes
Jun 16, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Annayya R AroorVincent G DeMarco
Sep 18, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Ippei KanazawaToshitsugu Sugimoto
Mar 11, 2015·Clinical Therapeutics·Cyrus V DesouzaAnery Patel

❮ Previous
Next ❯

Citations

Sep 15, 2016·Journal of Diabetes and Its Complications·Lea DuvnjakKristina Blaslov
Apr 11, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Masakazu HanedaMakoto Ueno
Jan 10, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Takamasa IwakuraHans Joachim Anders
Oct 28, 2018·Journal of Cellular Physiology·Habib YaribeygiAmirhossein Sahebkar
Mar 1, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Davide ViggianoGiovambattista Capasso
May 31, 2020·International Journal of Molecular Sciences·Sandra Rayego-MateosJesús Egido
Nov 8, 2016·Current Opinion in Nephrology and Hypertension·Yuta TakagakiKeizo Kanasaki
Nov 2, 2019·Pharmacological Reports : PR·Mai M Helmy, Samar M Mouneir
Feb 11, 2021·Antioxidants·Daiji KawanamiMakito Tanabe
Feb 1, 2020·Pharmacological Reports : PR·Mai M Helmy, Samar M Mouneir
Jun 20, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ramona NicoteraGiuseppe Coppolino
May 5, 2021·Metabolic Syndrome and Related Disorders·Jiao HeJun Wang
Feb 27, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Nattavadee PengrattanachotAnusorn Lungkaphin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis